FI891718A0 - Foerfarande foer att befria cellblandningar och vaevnader av icke-oenskade populationer. - Google Patents

Foerfarande foer att befria cellblandningar och vaevnader av icke-oenskade populationer.

Info

Publication number
FI891718A0
FI891718A0 FI891718A FI891718A FI891718A0 FI 891718 A0 FI891718 A0 FI 891718A0 FI 891718 A FI891718 A FI 891718A FI 891718 A FI891718 A FI 891718A FI 891718 A0 FI891718 A0 FI 891718A0
Authority
FI
Finland
Prior art keywords
vaevnader
populationer
oenskade
cellblandningar
befria
Prior art date
Application number
FI891718A
Other languages
English (en)
Other versions
FI891718L (fi
FI891718A7 (fi
Inventor
Peter Nemeth
Timea Berki
Original Assignee
Peter Nemeth
Timea Berki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peter Nemeth, Timea Berki filed Critical Peter Nemeth
Publication of FI891718L publication Critical patent/FI891718L/fi
Publication of FI891718A0 publication Critical patent/FI891718A0/fi
Publication of FI891718A7 publication Critical patent/FI891718A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI891718A 1987-08-12 1988-08-11 Menetelmä ei-toivottujen kantojen soluseosten ja kudosten vapauttamise ksi FI891718A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU873651A HU204856B (en) 1987-08-12 1987-08-12 Process for releasing cell mixtures and tissues from undesired populations and for producing monoclonal antibody - hematoporphyrin conjugates
PCT/HU1988/000057 WO1989001630A1 (en) 1987-08-12 1988-08-11 Procedure for relieving cell mixtures and tissues of unwanted populations

Publications (3)

Publication Number Publication Date
FI891718L FI891718L (fi) 1989-04-11
FI891718A0 true FI891718A0 (fi) 1989-04-11
FI891718A7 FI891718A7 (fi) 1989-04-11

Family

ID=10964922

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891718A FI891718A7 (fi) 1987-08-12 1988-08-11 Menetelmä ei-toivottujen kantojen soluseosten ja kudosten vapauttamise ksi

Country Status (6)

Country Link
EP (1) EP0327633B1 (fi)
DE (1) DE3885733T2 (fi)
DK (1) DK173189D0 (fi)
FI (1) FI891718A7 (fi)
HU (1) HU204856B (fi)
WO (1) WO1989001630A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
WO1991017188A1 (en) * 1990-05-08 1991-11-14 A.B. Technolody Pty. Limited Separation of mammalian semen into fractions enriched either for spermatozoa containing an x chromosome or for spermatozoa contai ning a y chromosome
GB9014307D0 (en) * 1990-06-27 1990-08-15 Scient Generics Ltd Method of treatment and compositions therefor
US5587394A (en) * 1991-03-28 1996-12-24 The University Of Toledo Production and use of diels alder adducts of vinyl porphyrins, of metal complexes thereof, and of compositions containing such adducts and complexes
IL102645A (en) * 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
EP0649667B1 (en) * 1993-10-20 2001-02-28 Antonella Aprile Carpenter Quantum energy therapeutic biostimulation apparatus
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US5874266A (en) 1997-03-27 1999-02-23 Palsson; Bernhard O. Targeted system for removing tumor cells from cell populations
US6514722B2 (en) 1997-03-27 2003-02-04 Oncosis Method and apparatus for selectively targeting specific cells within a cell population
US6753161B2 (en) 1997-03-27 2004-06-22 Oncosis Llc Optoinjection methods
US6642018B1 (en) 1998-03-27 2003-11-04 Oncosis Llc Method for inducing a response in one or more targeted cells
JP2004512845A (ja) 2000-10-24 2004-04-30 オンコシス　リミテッド　ライアビリティ　カンパニー 三次元の検体内の細胞を選択的に標的化する方法およびデバイス
GB0121023D0 (en) 2001-08-30 2001-10-24 Norwegian Radium Hospital Res Compound
US7425426B2 (en) 2004-03-15 2008-09-16 Cyntellect, Inc. Methods for purification of cells based on product secretion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3039157A1 (de) * 1979-10-17 1981-08-27 Fisher Scientific Co., 15219 Pittsburgh, Pa. Markiertes konjugat fuer immunologische bestimmungen
US5238808A (en) * 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
JPS6251990A (ja) * 1985-08-29 1987-03-06 Nippon Zeon Co Ltd 微生物菌体の処理方法

Also Published As

Publication number Publication date
EP0327633A1 (en) 1989-08-16
DE3885733D1 (de) 1993-12-23
WO1989001630A1 (en) 1989-02-23
FI891718L (fi) 1989-04-11
DK173189A (da) 1989-04-11
DK173189D0 (da) 1989-04-11
DE3885733T2 (de) 1994-03-10
EP0327633B1 (en) 1993-11-18
FI891718A7 (fi) 1989-04-11
HU204856B (en) 1992-02-28
HUT47601A (en) 1989-03-28

Similar Documents

Publication Publication Date Title
FI891718A0 (fi) Foerfarande foer att befria cellblandningar och vaevnader av icke-oenskade populationer.
DK499086D0 (da) Konjugater af trichothecen og anvendelse af samme som terapeutisk substans
NO885199D0 (no) FremgangsmŸte for fremstilling av monoklonale antistoffkonjugater.
ES2036737T3 (es) Procedimiento para la obtencion de mezclas farmaceuticas.
EA199700143A1 (ru) Способ и композиция ждя липидизации гидрофильных молекул
DE69029257D1 (de) Anordnung zur bestrahlung von laserstrahlen
CA2090700A1 (en) Modified antibodies with controlled clearance time
ES2010226A6 (es) Un procedimiento para producir una preparacion farmaceutica estable que contiene un factor estimulante de colonias de granulocitos
EP0330201A3 (en) Method of enhancing the effect of cytotoxic agents
IL84866A (en) Intraoperative and endoscopic tumor detection
ES2065906T3 (es) Produccion de proteinas en formas activas.
NO901986D0 (no) Nytt antistoff-leveringssystem for biologisk respons-modifiserende midler.
MX9603479A (es) Derivados de 4-amino de acido micofenolico con actividad inmunosupresora.
ATE125362T1 (de) Monoklonale antikörper gegen glykosyliertes albumin, hybride zellinien, die diese antikörper produzieren, sowie deren verwendung.
WO1997029779A3 (en) EGF-Genistein conjugates for the treatment of cancer
ES2110230T3 (es) Ensayo de rapamicina.
FI871345A0 (fi) Zwitterjoniska, bicykliska foereningar och deras salter, solvater, hydrater och estrar.
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
ES8403623A1 (es) Procedimiento para la determinacion de bilirrubina directa y total en liquidos corporales.
ATE67507T1 (de) Immunotoxine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
NO912621D0 (no) Fremgangsmaate for innfoering av dna i animalske celler.
ATE193534T1 (de) Benzodiazepin-derivate sowie deren konjugate mit proteinen und polypeptiden
ES473087A1 (es) Procedimiento para la preparacion de eritrocitos intactos modificados.
NO891491L (no) Prosedyre for befrielse av celleblandinger og vev for uoenskede populasjoner.

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: NéMETH, PéTER

Owner name: BERKI, TIMEA